PAUL C GRINT

CIK 1236548 · Chief Executive Officer · last filed 2024-07-18

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.35M

Companies

4

Total Filings

29

Lifetime Open-Market Net

-$1.46M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
IKT Director $1.67 $0 5 2024-07-18
Armata Pharmaceuticals, Inc. (APHB) Delisted Chief Executive Officer 599 $0 3 2017-12-12
Regulus Therapeutics Inc. (RGLS) Delisted President & CEO $8.16 $0 8 2017-02-23
ILMN Director 8,365 $160.97 $1.35M -$1.46M 13 2013-01-07

Recent Filings · Page 3 of 3

29 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2012-04-09 ILMN Grant (A) +314 $0 EDGAR
2011-05-12 ILMN Grant (A) +1,440 $0 EDGAR
2010-10-29 ILMN Mixed -$426.5K EDGAR
2010-10-29 ILMN Mixed -$514.5K EDGAR
2010-08-03 ILMN Mixed -$391.2K EDGAR
2010-05-12 ILMN Mixed +1,000 -$33.5K EDGAR
2009-05-11 ILMN Mixed +1,200 -$29.1K EDGAR
2008-05-20 ILMN Grant (A) +1,000 $0 EDGAR
2007-07-25 ILMN Grant (A) $0 EDGAR
Showing 2129 of 29
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.